Vaxcyte (PCVX) Earnings Date, Estimates & Call Transcripts $111.51 +3.05 (+2.81%) (As of 02:58 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Aug. 6) -$1.10 Beat By $0.04 Consensus EPS (Aug. 6) -$1.14 Conference Call TranscriptConference Call AudioEarnings Press Release Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePCVX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PCVX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Vaxcyte Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($1.00)($0.80)($0.90)Q2 20242($1.00)($0.86)($0.93)Q3 20242($0.88)($0.79)($0.84)Q4 20242($0.95)($0.78)($0.87)FY 20248($3.83)($3.23)($3.53)PCVX Earnings Date and InformationVaxcyte last posted its quarterly earnings results on August 6th, 2024. The reported ($1.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.14) by $0.04. Vaxcyte has generated ($4.28) earnings per share over the last year (($4.28) diluted earnings per share). Earnings for Vaxcyte are expected to decrease in the coming year, from ($4.33) to ($4.89) per share. Vaxcyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More Vaxcyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 8/6/2024Q2 2024($1.14)($1.10)+$0.04($1.10)-- 5/8/2024Q1 2024($1.13)($0.85)+$0.28($0.85)-- 2/27/2024Q4 2023($0.89)($1.82)($0.93)($1.82)-- 11/6/2023Q3 2023($0.84)($0.91)($0.07)($0.91)-- 8/8/2023Q2 2023($0.74)($0.70)+$0.04($0.70)-- 5/8/2023Q1 2023($0.80)($0.70)+$0.10($0.70)-- [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play.2/27/2023Q4 2022($0.84)($0.73)+$0.11($0.43)-- 11/7/2022Q3 2022($0.80)($0.93)($0.13)($0.93)--8/8/2022Q2 2022($0.69)($0.80)($0.11)($0.80)--5/9/2022Q1 2022($0.56)($0.68)($0.12)($0.68)--2/28/2022Q4 2021($0.46)($0.54)($0.08)($0.54)--11/10/2021Q3 2021($0.55)($0.51)+$0.04($0.51)--8/11/2021Q2 2021($0.52)($0.46)+$0.06($0.46)--5/11/2021Q1 2021($0.51)($0.41)+$0.10($0.41)-- 3/28/2021Q4 2020($0.54)($0.41)+$0.13($0.41)-- 11/12/2020Q3 2020($0.44)($0.41)+$0.03($0.41)-- 8/12/2020Q2 2020($0.66)($1.72)($1.06)($1.72)-- Vaxcyte Earnings - Frequently Asked Questions When is Vaxcyte's earnings date? Vaxcyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on PCVX's earnings history. Did Vaxcyte beat their earnings estimates last quarter? In the previous quarter, Vaxcyte (NASDAQ:PCVX) reported ($1.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.14) by $0.04. Learn more on analysts' earnings estimate vs. PCVX's actual earnings. How can I listen to Vaxcyte's earnings conference call? The conference call for Vaxcyte's latest earnings report can be listened to online. Listen to Conference Call How can I read Vaxcyte's conference call transcript? The conference call transcript for Vaxcyte's latest earnings report can be read online. Read Transcript How much profit does Vaxcyte generate each year? Vaxcyte (NASDAQ:PCVX) has a recorded net income of -$402.27 million. PCVX has generated -$4.28 earnings per share over the last four quarters. What is Vaxcyte's EPS forecast for next year? Vaxcyte's earnings are expected to decrease from ($4.33) per share to ($4.89) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SRRK Earnings Date EDIT Earnings Date SGMO Earnings Date ADVM Earnings Date ATRA Earnings Date TAK Earnings Date BNTX Earnings Date BGNE Earnings Date MRNA Earnings Date TEVA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:PCVX) was last updated on 10/8/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, G...Manward Press | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCVX Stock Alerts